Kala Bio, Inc. is a biopharmaceutical company. It focuses on the development and commercialization of therapeutics using proprietary nanoparticle-based mucus penetrating particles with an initial focus on the treatment of eye diseases. The company was founded by Justin Hanes, Robert S. Langer and Colin R. Gardner in 2009 and is headquartered in Arlington, MA.
Fundamentals
Mkt Cap
$5.74M
Volume
-
52W High
$95.50
52W Low
$0.286
PE Ratio
0.00
Avg. Volume
3.88M
EPS (Annual)
-$165.56
P/B
0.63
Rev/Employee
$0.00
Earnings
Aug 08
34
Bearish Sentiment
How do you feel about KALA?
thegoodcall
$KALA I called it at 3PM It will fly before closing or AG. Now I’m calling $EVGN will do 150% PM
6
Mr_Stochastic
$KALA holding some for potential run tomorrow. Why not. Had a very profitable day on this stock and others 💪🏼😎💰
5
Fakhrul123
$KALA as a longterm holder, my average is $5+ after last RS!!! If it can drop from $20 to .5; it’ll go up to $10 again with right outcomes.
5
MrTicker
$KALA lets see if this cracks the 10 day at .5990 to test the 30 day at .72 then .95 for the high
1
2
thematrix16
$KALA if you have 1,000,000 million dollars in buying power then put
500,000 on at .61
300,000 on at .62
200,000 on at.63
1
1
The_Assassin
$KALA looks interesting
KALA Bio Signs Non-Binding LOI to Acquire Nationwide Telehealth Platform with Approximately $48 Million in Sales Since Inception
4
ony2k
$KALA What's the chance of recovering some losses if I hold because of the Virotek deal?I'm thinking dump before incurring more loss in up to now, a total POS.
1
Rachs88
$KALA I was in both and if this is not market manipulation by the MMs then don't know what is.
2
Luckytoo8
$KALA A secured promissory note of Kala Bio, Inc. details a $7,000,000 USD loan made to borrower Minglemint Solutions LLC on February 9, 2026
2
MarsMaxxing
$KALA we saw her run and she'll go again but wouldn't hold your breath maybe next week
1
Donniechen12345
$KALA pump it up and trash it all the down to raise $15 million to buy a company ,lmao fuking trash !!!!!! Scam another epic scam smh … going to .05 cents lmao
1
Kennyk93
$KALA let it be a p and d up until the shareholders meeting. Who cares. Just be out by then regardless of the outcome
1
Barekzai
$KALA I am so stupid bought it at .76 sold it at .71 and than bought it again at .86 now I can’t sleep tonight this thing better open at $2 🤣
1
plmajor
$KALA news about the aquisition broke out this morning--why is it moving in extended hours? strangely, it took all day to move--looks like the dam broke out hard!! especially above the 200 EMA @ 17:33--damn, lol!
1
EnronRetirementPlan
$KALA Be Careful KALA BIO Inc (KALA) faces a high ongoing dilution risk due to its active S-3 shelf registration and a short cash runway.
• ⚠️ Active Shelf Registration: The company maintains an S-3 filing authorizing potential future share issuance.
1
RTPRwire
$KALA is moving on M&A / acquisition following a Newsfile Corp release.
KALA Bio signed a non-binding LOI to acquire a 50-state telehealth platform for ~$15M, which generated $12.7M in trailing twelve-month revenue and serves over 90,000 clients.
RTPR pushed this release out to users at 7:30:15 AM ET
1
focafoca99
$KALA locked in an exclusive distribution and reseller agreement with Virotek for ophthalmology genetic testing.
1
Billypouli
$KALA lazy do to some DD here- in shorts- what’s up with this, it’s like a 52 week low each day?
Nousernam3
$KALA sell the pop and join the shorts on the way down. Adapt to the market or keep losing
SFG1
$KALA 1. The election of two Class III directors, Yonatan Colman and Brendan Purdy, each to serve until the 2029 annual meeting of stockholders and until his successor has been duly elected and qualified;
2. The approval of a non-binding advisory vote on executive compensation;
3. The ratification of the appointment of HTL International, LLC as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
4. The approval of an amendment to our Restated Certificate of Incorporation, as amended, to effect a reverse stock split of the shares of our common stock at a ratio of not less than 1-for-2 and not greater than 1-for-300
5. The approval of an adjournment of the 2026 annual meeting, if necessary, to solicit additional proxies if there are not sufficient votes in favor of the foregoing proposals at the time of the meeting, or in the absence of a quorum; and